-
NPPA updates provisional list of pharma, med-devices companies’ overcharging cases
expresspharma
January 13, 2021
The National Pharmaceutical Pricing Authority (NPPA), updated the list of provisional overcharging cases on its website, on January 11, 2021.
-
Value of pharma’s M&A deals remain high, despite COVID-19
europeanpharmaceuticalreview
January 11, 2021
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
-
Indifi partners with Retailio, strengthening its presence in pharma
expresspharma
January 07, 2021
The partnership aims to serve 100,000 retailers with a widespread network of Retailio.
-
Fighting counterfeiting requires a long-term battle and we need to start somewhere
expresspharma
January 06, 2021
COVID-19 vaccines are here but there are reports about a surge in the cyber attacks in the pharma sector as well. How can a data breach become a critical, serious event?
-
Open innovation in drug development
expresspharma
December 28, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca shares insights on how greater transparency in drug development could deliver quicker, more affordable solutions.
-
Pandemic has made little positive impact on public's view of pharma
pharmatimes
December 16, 2020
Contrary to popular belief COVID-19 has actually had little positive impact on perceptions of pharmaceutical companies, finds a new report launched by Takeda UK.
-
COVID-19 expedites India’s focus on innovation within pharma: GlobalData
expresspharma
December 16, 2020
According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020.
-
Indifi forays into pharma segment along with Marg ERP
expresspharma
December 07, 2020
Indifi will be extending its credit line solution to pharma distributors and local chemists for managing their working capital needs and cash flows using the Margpay platform.
-
Annual pharma R&D spending in UK climbed 6.9% in 2019
pharmatimes
November 24, 2020
Annual research and development (R&D) spending in the UK’s pharmaceutical sector climbed by 6.9% last year, representing an eight-year high point, according to tax relief specialist Catax.
-
Govt of India is committed to improvement of pharma profession and industry: Gowda
expresspharma
November 24, 2020
Proactively looking to provide industrial parks with facilities to grow API, pharma and nutra industry, said the Minister.